DOJ declines to charge US biomedical company for Mexico bribery scheme

The DOJ said Lifecore Biomedical voluntarily self-disclosed the corruption scheme within three months of opening an internal investigation and quickly remediated the misconduct, which occurred as it was acquiring another company.

Unlock unlimited access to all Global Investigations Review content